MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.94 -1.2

Resumen

Variación precio

24h

Actual

Mínimo

18.78

Máximo

19.51

Métricas clave

By Trading Economics

Ingresos

-681K

Ventas

17M

P/B

Media del Sector

48.528

87.826

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

-79M

-74M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+6.38% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

8 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

19M

387M

Apertura anterior

20.14

Cierre anterior

18.94

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

166 / 372 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ene 2026, 23:11 UTC

Ganancias

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ene 2026, 22:55 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ene 2026, 21:39 UTC

Principales Movimientos del Mercado

Raytheon Down Following Trump Post Criticizing Company

7 ene 2026, 20:13 UTC

Principales Movimientos del Mercado

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ene 2026, 20:03 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ene 2026, 23:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 ene 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ene 2026, 23:42 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ene 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ene 2026, 23:29 UTC

Adquisiciones, fusiones, absorciones

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ene 2026, 22:48 UTC

Charlas de Mercado

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ene 2026, 22:46 UTC

Ganancias

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ene 2026, 22:45 UTC

Ganancias

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ene 2026, 22:42 UTC

Ganancias

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ene 2026, 22:40 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ene 2026, 22:31 UTC

Charlas de Mercado

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ene 2026, 22:22 UTC

Charlas de Mercado

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ene 2026, 22:01 UTC

Charlas de Mercado

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

7 ene 2026, 21:46 UTC

Charlas de Mercado

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ene 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ene 2026, 21:18 UTC

Adquisiciones, fusiones, absorciones

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ene 2026, 20:29 UTC

Adquisiciones, fusiones, absorciones

AbbVie Near Deal for Revolution Medicines -- Update

7 ene 2026, 20:27 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ene 2026, 19:58 UTC

Charlas de Mercado

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ene 2026, 19:48 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

6.38% repunte

Estimación a 12 Meses

Media 20.5 USD  6.38%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

166 / 372 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat